Literature DB >> 27791948

The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.

Berivan Bitik1, Abdurrahman Tufan2, Kubilay Sahin3, Yesim Sucullu Karadag4, Sevinc Can Sandikci3, Ridvan Mercan2, Fikri Ak4, Yasar Karaaslan5, Mehmet Akif Ozturk2, Berna Goker2, Seminur Haznedaroglu2.   

Abstract

OBJECTIVES: Behçet's syndrome (BS) is a systemic vasculitis, which may involve multiple organ systems simultaneously. Clinical findings in BS often fit into well-recognized patterns, such as the association between papulo-pustular skin lesions and arthritis. We have recently observed a distinct pattern, in which a subtype of neuro-Behçet's syndrome (NBS) is often preceded by specific ophthalmic manifestations of the disease process. The purpose of this study is to evaluate the association between the parenchymal subtype of NBS and posterior uveitis (PU).
METHODS: We have retrospectively reviewed the clinical records of 295 patients with BS, who met the international classification criteria for BS, diagnosed at two major rheumatology clinics from 2010 to 2014. Patient demographics, ophthalmic examinations, clinical and radiologic patterns of neurological involvement were recorded. Manifestations of BS were classified as PU, NBS, vascular involvement, and arthritis. The association between clinical findings was analysed for statistical significance.
RESULTS: Of the 295 patients, 100 had PU and 44 had NBS. 30 patients had parenchymal NBS and 14 had vascular NBS. Patients with PU were significantly more likely to have neurological involvement compared to those without PU (p<0.001; Odds Ratio: 3.924; 95% CI: 1.786-8.621). Rate of posterior uveitis was higher in patients with parenchymal NBS when compared to patients with vascular NBS, vascular BS or arthritis (63.3%, 21.4%, 22% and 4.2% respectively, p<0.001).
CONCLUSIONS: Our findings suggest a clinically and statistically significant association between posterior uveitis and parenchymal type of neurologic involvement in BS. The development of posterior uveitis in a patient with previously diagnosed BS should be recognized as a "warning sign" for predisposition to neurologic involvement. These patients should be informed about the possible signs and symptoms of neurological involvement, which can cause very rapid and irreversible damage unless recognized and treated immediately.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27791948

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Authors:  Jurgen Sota; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Ida Orlando; Gian Marco Tosi; Bruno Frediani; Antonio Vitale; Silvana Guerriero; Florenzo Iannone; Lorenzo Vannozzi; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2020-02-01       Impact factor: 3.397

2.  Characteristics and phenotype heterogeneity in late-onset Behçet's syndrome: a cohort from a referral center in China.

Authors:  Jun Zou; Dan Luo; Yan Shen; Jian-Long Guan
Journal:  Clin Rheumatol       Date:  2021-01-07       Impact factor: 2.980

Review 3.  Parenchymal neuro-Behçet disease with erectile dysfunction and micturition disturbances: case report and literature review.

Authors:  Ali Taylan; Merih Birlik
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

Review 4.  Phenotypes in Behçet's syndrome.

Authors:  Emire Seyahi
Journal:  Intern Emerg Med       Date:  2019-02-11       Impact factor: 3.397

5.  Prognostic factors for relapse and poor outcome in neuro-Behçet's syndrome: results from a clinical long-term follow-up of a single centre.

Authors:  Didem Sahin Eroglu; Murat Torgutalp; Canan Yucesan; Serdar Sezer; Mucteba Enes Yayla; Ayse Boyvat; Askin Ates
Journal:  J Neurol       Date:  2021-09-04       Impact factor: 4.849

6.  The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease.

Authors:  Dong Yan; JinJing Liu; Yuehua Zhang; Wei Yuan; Yan Xu; Jing Shi; Chaoran Li; Yining Wang; Linyi Peng; Yunjiao Yang; Jiaxin Zhou; Di Wu; Zhichun Liu; Xiaofeng Zeng; Fengchun Zhang; Wenjie Zheng; Yan Zhao
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

Review 7.  Treating the Different Phenotypes of Behçet's Syndrome.

Authors:  Alessandra Bettiol; Gulen Hatemi; Lorenzo Vannozzi; Alessandro Barilaro; Domenico Prisco; Giacomo Emmi
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

8.  Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis.

Authors:  Duygu Tecer; Feride Gogus; Ayse Kalkanci; Merve Erdogan; Murat Hasanreisoglu; Çagri Ergin; Tarkan Karakan; Ramazan Kozan; Seda Coban; Kadir Serdar Diker
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.